Originally posted by jatter:
↑
I use to be a big holder here and if it works, probably worth what they're trading at. But just had a look at the oppies on issue, now at 625,275,687. Add to that the shares on issue at 3.6b, its almost 20%.
Expand
Originally posted by jatter:
↑
I use to be a big holder here and if it works, probably worth what they're trading at. But just had a look at the oppies on issue, now at 625,275,687. Add to that the shares on issue at 3.6b, its almost 20%.
Expand
Originally posted by jatter:
↑
I use to be a big holder here and if it works, probably worth what they're trading at. But just had a look at the oppies on issue, now at 625,275,687. Add to that the shares on issue at 3.6b, its almost 20%.
Expand
One never knows when the takeover or partnership comes. Takeover most likely during a lull and low share price.
I’m not saying that will happen soon but I’d rather be in than out with this one. If the B cell shows it efficacy early things could get interesting veey quickly.
(20min delay)
